Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy

Journal of Clinical Oncology

Volumn 18, Issue 2, 2000, Pages 307-316

  Koç, Omer N ^a   Gerson, Stanton L ^a   Cooper, Brenda W ^a   Dyhouse, Stephanie M ^a   Haynesworth, Stephen E ^a   Caplan, Arnold I ^a   Lazarus, Hillard M ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CD45 ANTIGEN; CYCLOPHOSPHAMIDE; MESNA; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ARTICLE; AUTOTRANSPLANTATION; BREAST CANCER; CLINICAL ARTICLE; CLONOGENESIS; CONTROLLED STUDY; DRUG MEGADOSE; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MESENCHYME; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0033977382     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/jco.2000.18.2.307     Document Type: Article

References (34)

1. Bruder SP, Jaiswal N, Haynesworth SE: Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J Cell Biochem 64:278-294, 1997
2. Haynesworth SE, Goshima J, Goldberg VM, et al: Characterization of cells with osteogenic potential from human marrow. Bone 13:81-88, 1992
3. Pittinger MF, Mackay A, Beck SC, et al: Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147, 1999
4. Haynesworth S, Baber M, Caplan A: Cell surface antigens on human marrow-derived mesenchymal cells are detected by monoclonal antibodies. Bone 13:69-80, 1992
5. Majumdar MK, Thiede MA, Mosca JD, et al: Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells. J Cell Physiol 176:186-192, 1998
6. Lazarus HM, Haynesworth SE, Gerson SL, et al: Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): Implications for therapeutic use. Bone Marrow Transplant 16:557-564, 1995
7. Lennon DP, Haynesworth SE, Bruder SP, et al: Development of a serum screen for mesenchymal progenitor cells from bone marrow. In Vitro Cell Dev Biol 32:602-611, 1996
8. Ross A, Cooper BW, Lazarus HM, et al: Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques. Blood 82:2605-2610, 1993
9. Koç ON, Gerson SL, Phillips GL, et al: Autologous CD34+ cell transplantation for patients with advanced lymphoma: Effects of overnight storage on peripheral blood progenitor cell enrichment and engraftment. Bone Marrow Transplant 21:337-344, 1998
10. Lazarus HM, Andersen J, Chen M, et al: Recombinant GM-CSF after autologous bone marrow transplantation for relapsed non-Hodgkin's lymphoma: Blood and bone marrow progenitor growth studies - A phase II Eastern Cooperative Oncology Group trial. Blood 78:830-837, 1991
11. Antman K, Ayash LJ, Elias A, et al: A phase II study of high dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy. J Clin Oncol 10:102-110, 1992
12. Tavassoli M, Friedenstein A: Hematopoietic stromal microenvironment. Am J Hematol 15:195-293, 1983
13. Nolta J, Hanley M, Kohn D: Sustained human hematopoiesis in immunodeficient mice by cotransplantation of marrow stroma expressing human interleukin-3: Analysis of gene transduction of long-lived progenitors. Blood 83:3041-3051, 1994
14. Fried W, Kedo A, Barone J: Effects of cyclophosphamide and of busulfan on spleen colony-forming units and on hematopoietic stroma. Cancer Res 37:1205-1209, 1977
15. McManus PM, Weiss L: Busulfan-induced chronic bone marrow failure: Changes in cortical bone, marrow stromal cells, and adherent cell colonies. Blood 64:1036-1041, 1984
16. Migliaccio A, Migliaccio G, Johnson G, et al: Comparative analysis of hematopoietic growth factor released by stromal cells from normal donors or transplant patients. Blood 75:305-312, 1990
17. O'Flaherty E, Sparrow R, Szer J: Bone marrow stromal function from patients after bone marrow transplantation. Bone Marrow Transplant 15:207-212, 1995
18. Uhlman DL, Verfaillie C, Jones RB, et al: BCNU treatment of marrow stromal monolayers reversibly alters haematopoiesis. Br J Haematol 78:3304-309, 1991
19. Shpall EJ, Jones RB, Bearman S, et al: Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: Influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment. J Clin Oncol 12:28-36, 1994
20. deMagalhaes-Silverman M, Rybka W, Lembersky B: High-dose cyclophosphamide, carboplatin, and etoposide with autologous stem cell rescue in patients with breast cancer. Am J Clin Oncol 19:169-173, 1996
21. Cagnoni PJ, Nieto Y, Shpall EJ, et al: High-dose chemotherapy with autologous hematopoietic progenitor-cell support as part of combined modality therapy in patients with inflammatory breast cancer. J Clin Oncol 16:1661-1668, 1998
22. Bitran JD, Samuels B, Klein L, et al: Tandem high-dose chemotherapy supported by hematopoietic progenitor cells yields prolonged survival in stage IV breast cancer. Bone Marrow Transplant 17:157-162, 1996
23. Ayash LJ, Elias A, Wheeler C, et al: Double-dose intensive chemotherapy with autologous marrow and peripheral blood progenitor cell support for metastatic breast cancer: A feasibility study. J Clin Oncol 12:37-44, 1994
24. El-Badri N, Wang B-Y, Good R: Osteoblasts promote engraftment of allogeneic hematopoietic stem cells. Exp Hematol 26:110-116, 1998
25. Lazarus HM, Haynesworth SE, Gerson SL, et al: Human bone marrow-derived mesenchymal (stromal) progenitor cells (MPCS) cannot be recovered from peripheral blood progenitor cell collections. J Hematother 6:447-455, 1997
26. Simmons PJ, Przepiorka D, Thomas ED, et al: Host origin of marrow stromal cells following allogeneic bone marrow transplantation. Nature 328:429-432, 1987
27. Huss R, Smith FO, Myerson DH, et al: Homing and immunogenicity of murine stromal cells transfected with xenogeneic MHC class II genes. Cell Transplant 4:483-491, 1995
28. Hurwitz D, Krichgesser M, Merrill W, et al: Systemic delivery of human growth hormone or human factor IX in dogs by reintroduced genetically modified autologous bone marrow stromal cells. Human Gene Therapy 8:137-156, 1997
29. Anklesaria P, Kase K, Glowacki J, et al: Engraftment of a clonal bone marrow stromal cell line in vivo stimulates hematopoietic recovery from total body irradiation. Proc Natl Acad Sci USA 1987:7681-7685, 1987
30. Pereira RF, O'Hara MD, Laptev AV, et al: Marrow stromal cells as a source of progenitor cells for non-hematopoietic tissue in transgenic mice with a phenotype of osteogenesis imperfecta. Proc Natl Acad Sci U S A 95:1142-1147, 1998
31. Mosca J, Buyaner D, Kniley J, et al: Biodistribution and bone marrow "homing" of canine mesenchymal stem cells after culture expansion and re-infusion into a canine transplantation model. Blood 92:664a, 1998 (abstr)
32. Sandmaier B, Strob R, Kniley J, et al: Evidence of allogeneic stromal engraftment in bone marrow using canine mesenchymal stem cells. Blood 92:116a, 1998 (abstr)
33. Novelli E, Buyaner D, Chopra R, et al: Human mesenchymal stem cells can enhance human CD34+ cell repopulating of NOD/SCID mice. Blood 92:117a, 1998 (abstr)
34. Liechty K, Milner R, Shaaban A, et al: Distribution and engraftment of human mesenchymal stem cells after in utero transplantation in fetal sheep. Blood 92:117a, 1998 (abstr)